By Katherine Hamilton
Eastman Kodak expanded its pharmaceuticals portfolio to add four new products.
The products include a phosphate buffered saline in two different formulations and water for injection in two formulations.
They are immediately available for order by U.S. research laboratories, biopharmaceutical developers and contract development and manufacturing organizations, the Rochester, N.Y., manufacturer said Monday.
The water for injection products are Kodak's first offerings in that category.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
January 26, 2026 13:30 ET (18:30 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.